BeOne Medicines AG
BEIGF
$21.95
-$0.56-2.48%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.04B | 5.66B | 5.28B | 4.92B | 4.52B |
| Total Other Revenue | 90.39M | 78.33M | 60.97M | 49.03M | 39.91M |
| Total Revenue | 6.13B | 5.74B | 5.34B | 4.97B | 4.56B |
| Cost of Revenue | 680.68M | 670.75M | 668.54M | 686.68M | 660.63M |
| Gross Profit | 5.45B | 5.07B | 4.67B | 4.29B | 3.90B |
| SG&A Expenses | 2.23B | 2.18B | 2.08B | 2.03B | 1.96B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.21B | 5.05B | 4.90B | 4.79B | 4.66B |
| Operating Income | 923.10M | 685.94M | 447.14M | 182.68M | -100.70M |
| Income Before Tax | 868.08M | 655.17M | 416.85M | 182.26M | -63.21M |
| Income Tax Expenses | 212.37M | 142.15M | 129.92M | 113.71M | 114.44M |
| Earnings from Continuing Operations | 655.71 | 513.02 | 286.93 | 68.55 | -177.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 655.71M | 513.02M | 286.93M | 68.55M | -177.64M |
| EBIT | 923.10M | 685.94M | 447.14M | 182.68M | -100.70M |
| EBITDA | 1.07B | 825.39M | 578.82M | 328.98M | 79.96M |
| EPS Basic | 76.78 | 60.49 | 34.01 | 7.62 | -22.00 |
| Normalized Basic EPS | 5.18 | 4.04 | 2.71 | 1.18 | -0.32 |
| EPS Diluted | 72.71 | 55.81 | 30.61 | 5.06 | -23.67 |
| Normalized Diluted EPS | 4.98 | 3.88 | 2.61 | 1.11 | -0.35 |
| Average Basic Shares Outstanding | 443.48M | 440.22M | 436.19M | 431.72M | 427.41M |
| Average Diluted Shares Outstanding | 35.50M | 35.25M | 34.89M | 34.19M | 33.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -8.16% |